Analyst Ratings For Abbott Laboratories (NYSE:ABT)
Today, Barclays PLC reiterated its Overweight rating on Abbott Laboratories (NYSE:ABT) with a price target of $57.00.
There are 3 hold ratings, 11 buy ratings on the stock.
The current consensus rating on Abbott Laboratories (NYSE:ABT) is Buy (Score: 2.79) with a consensus target price of $52.77 per share, a potential 3.79% upside.
Some recent analyst ratings include
- 7/22/2017-Barclays PLC Reiterated Rating of Overweight.
- 7/21/2017-Stifel Nicolaus Reiterated Rating of Buy.
- 7/14/2017-Cowen and Company Reiterated Rating of Outperform.
- 7/11/2017-BMO Capital Markets Reiterated Rating of Hold.
- 7/10/2017-Morgan Stanley Reiterated Rating of Equal Weight.
- 6/30/2017-Wells Fargo & Company Reiterated Rating of Outperform.
- 6/29/2017-Jefferies Group LLC Reiterated Rating of Buy.
Dividend information for Abbott Laboratories (NYSE:ABT)
Abbott Laboratories (NYSE:ABT) pays an annual dividend of Community Ranking: with a yield of 2.08% and an average dividend growth of 22.90% based on a 3 Year Average.
Dividend History for Abbott Laboratories (NYSE:ABT)
- On 6/9/2017 Abbott Laboratories announced a quarterly dividend of $0.27 2.25% with an ex dividend date of 7/12/2017 which will be payable on 8/15/2017.
- On 2/17/2017 Abbott Laboratories announced a quarterly dividend of $0.27 2.36% with an ex dividend date of 4/11/2017 which will be payable on 5/15/2017.
- On 12/9/2016 Abbott Laboratories announced a quarterly dividend of $0.27 2.7% with an ex dividend date of 1/11/2017 which will be payable on 2/15/2017.
- On 9/15/2016 Abbott Laboratories announced a quarterly dividend of $0.26 2.48% with an ex dividend date of 10/12/2016 which will be payable on 11/15/2016.
- On 6/10/2016 Abbott Laboratories announced a quarterly dividend of $0.26 2.75% with an ex dividend date of 7/13/2016 which will be payable on 8/15/2016.
- On 2/19/2016 Abbott Laboratories announced a quarterly dividend of $0.26 2.66% with an ex dividend date of 4/13/2016 which will be payable on 5/16/2016.
- On 12/11/2015 Abbott Laboratories announced a quarterly dividend of $0.26 2.32% with an ex dividend date of 1/13/2016 which will be payable on 2/16/2016.
Recent Insider Trading Activity For Abbott Laboratories (NYSE:ABT)
Abbott Laboratories (NYSE:ABT) has insider ownership of 0.76% and institutional ownership of 71.02%.
- On 6/15/2017 Jared Watkin, Insider, sold 552 with an average share price of $47.97 per share and the total transaction amounting to $26,479.44. View SEC Filing
- On 6/8/2017 Stephen R Fussell, Insider, sold 196,550 with an average share price of $46.00 per share and the total transaction amounting to $9,041,300.00. View SEC Filing
- On 4/27/2017 Roger Bird, Insider, sold 5,600 with an average share price of $43.82 per share and the total transaction amounting to $245,392.00. View SEC Filing
- On 4/26/2017 Joseph J Manning, Insider, sold 4,200 with an average share price of $43.95 per share and the total transaction amounting to $184,590.00. View SEC Filing
- On 3/1/2017 Michael J. Warmuth, Insider, sold 3,851 with an average share price of $45.39 per share and the total transaction amounting to $174,796.89. View SEC Filing
- On 2/23/2017 Robert E Funck, VP, sold 25,500 with an average share price of $45.50 per share and the total transaction amounting to $1,160,250.00. View SEC Filing
- On 2/22/2017 Roger Bird, Insider, sold 13,222 with an average share price of $45.02 per share and the total transaction amounting to $595,254.44. View SEC Filing
Recent Trading Activity for Abbott Laboratories (NYSE:ABT)
Shares of Abbott Laboratories closed the previous trading session at 50.84 down -0.01 -0.02% with 7,980,288 shares trading hands.